IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $115,656 | -3.3% | 18,929 | +1.1% | 0.01% | -12.5% |
| Q4 2022 | $119,627 | -30.0% | 18,721 | +4.9% | 0.01% | -27.3% |
| Q3 2022 | $171,000 | -36.7% | 17,842 | +10.2% | 0.01% | -21.4% |
| Q1 2022 | $270,000 | +8.0% | 16,190 | +23.6% | 0.01% | -6.7% |
| Q4 2021 | $250,000 | -64.7% | 13,101 | -14.2% | 0.02% | -70.6% |
| Q4 2020 | $708,000 | +17.0% | 15,264 | -16.9% | 0.05% | +155.0% |
| Q3 2020 | $605,000 | – | 18,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |